Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma

Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma

Abstract Background Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC) incidence has been increasing in the United States for greater than 30 years. For the majority of EAC patients, treatment is limited and prognosis poor. Doublecortin like kinase-1 (DCLK1) is a cancer stem cell marker wi...

Full description

Bibliographic Details
Main Authors: Emily M. Christman, Parthasarathy Chandrakesan, Nathaniel Weygant, John T. Maple, William M. Tierney, Kenneth J. Vega, Courtney W. Houchen
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Biomarker Research
Subjects:
DCLK1
Doublecortin-like kinase 1
Esophageal adenocarcinoma
Cancer stem cell
ELISA
Online Access:http://link.springer.com/article/10.1186/s40364-019-0157-z

Internet

http://link.springer.com/article/10.1186/s40364-019-0157-z

Similar Items